Skip to main content
Erschienen in: Familial Cancer 3/2016

23.03.2016 | Original Article

Lynch syndrome in South America: past, present and future

verfasst von: Carlos A. Vaccaro, Carlos Sarroca, Benedito Rossi, Francisco Lopez-Kostner, Mev Dominguez, Natalia Causada Calo, Raul Cutait, Adriana Della Valle, Lina Nuñez, Florencia Neffa, Karin Alvarez, Maria Laura Gonzalez, Pablo Kalfayan, Henry T. Lynch, James Church

Erschienen in: Familial Cancer | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

After decades of unawareness about Lynch syndrome, the medical community in South America is increasingly interested and informed. The visits and support of mentors like H. T. Lynch had been crucial to this awakening. Several countries have at least one registry with skilled personnel in genetic counseling and research. However, this only represents a very restricted resource for the region. According to the GETH, there are 27 hereditary cancer care centers in South America (21 in Brazil, 3 in Argentina, 1 in Uruguay, 1 in Chile and 1 in Peru). These registries differ in fundamental aspects of function, capabilities and funding, but are able to conduct high quality clinical, research and educational activities due to the dedication and personal effort of their members, and organizational support. More support from the governments as well as the participation of the community would boost the initiatives of people leading these groups. Meantime, the collaboration among the South American registries and the involvement of registries and leaders from developed countries will allow to maximize the efficiency in caring for affected patients and their families. The aim of this article is to describe how the knowledge of LS began to be spread in South America, how the first registries were organized and to summarize the current state of progress. In addition, we will provide an update of the clinical and molecular findings in the region.
Literatur
1.
Zurück zum Zitat Church J, Kiringoda R, LaGuardia L (2004) Inherited colorectal cancer registries in the United States. Dis Colon Rectum 47:674–678CrossRefPubMed Church J, Kiringoda R, LaGuardia L (2004) Inherited colorectal cancer registries in the United States. Dis Colon Rectum 47:674–678CrossRefPubMed
3.
Zurück zum Zitat Sarroca C, Ferreira WA, Quadrelli R (1977) Cáncer colónico familiar sin poliposis: enfoque clínico y anátomo-patológico, Perspectivas de estudio genético. Cir del Urug 47:515–520 Sarroca C, Ferreira WA, Quadrelli R (1977) Cáncer colónico familiar sin poliposis: enfoque clínico y anátomo-patológico, Perspectivas de estudio genético. Cir del Urug 47:515–520
4.
Zurück zum Zitat Sarroca C, Quadrelli R, Praderi R (1978) Cancer colique familial. Nouv Press Med 7:1412 Sarroca C, Quadrelli R, Praderi R (1978) Cancer colique familial. Nouv Press Med 7:1412
5.
Zurück zum Zitat Raevaara TE et al (2003) Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. Gastroenterology 125:501–509CrossRefPubMed Raevaara TE et al (2003) Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. Gastroenterology 125:501–509CrossRefPubMed
6.
Zurück zum Zitat Vaccaro C, Bonadeo F, Benati M, Ojea Quintana G (1997) Sindrome de Lynch: implicancias de una patología subdignosticada. Rev Argent Cirug 3:110–120 Vaccaro C, Bonadeo F, Benati M, Ojea Quintana G (1997) Sindrome de Lynch: implicancias de una patología subdignosticada. Rev Argent Cirug 3:110–120
7.
Zurück zum Zitat Vaccaro C et al (2007) Hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Argentina: report from a referral hospital register. Dis Colon Rectum 50:1604–1611CrossRefPubMed Vaccaro C et al (2007) Hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Argentina: report from a referral hospital register. Dis Colon Rectum 50:1604–1611CrossRefPubMed
8.
Zurück zum Zitat Fullerton D, López F, Rahmer A (2004) Hereditary nonpolyposis colorectal cancer: surgical treatment and pedigree analysis. Rev Med Chil 132:539–547PubMed Fullerton D, López F, Rahmer A (2004) Hereditary nonpolyposis colorectal cancer: surgical treatment and pedigree analysis. Rev Med Chil 132:539–547PubMed
9.
Zurück zum Zitat Bellolio RF et al (2006) Cáncer colorrectal hereditario: análisis molecular de los genes APC y MLH1. Rev Med Chil 134:841–848CrossRef Bellolio RF et al (2006) Cáncer colorrectal hereditario: análisis molecular de los genes APC y MLH1. Rev Med Chil 134:841–848CrossRef
10.
Zurück zum Zitat Alvarez K et al (2010) Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome. Dis Colon Rectum 53:450–459CrossRefPubMed Alvarez K et al (2010) Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome. Dis Colon Rectum 53:450–459CrossRefPubMed
11.
Zurück zum Zitat Rossi B et al (2002) hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 9:555–561PubMed Rossi B et al (2002) hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 9:555–561PubMed
12.
Zurück zum Zitat Sarroca C et al (2005) Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer. Clin Genet 68:80–87CrossRefPubMed Sarroca C et al (2005) Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer. Clin Genet 68:80–87CrossRefPubMed
13.
Zurück zum Zitat Giraldo A et al (2005) MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)–description of four novel mutations. Fam Cancer 4:285–290CrossRefPubMed Giraldo A et al (2005) MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)–description of four novel mutations. Fam Cancer 4:285–290CrossRefPubMed
14.
Zurück zum Zitat Valentin MD et al (2011) Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 10:641–647CrossRefPubMed Valentin MD et al (2011) Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 10:641–647CrossRefPubMed
15.
Zurück zum Zitat Alonso-Espinaco V et al (2011) Novel MLH1 duplication identified in Colombian families with Lynch syndrome. Genet Med Off J Am Coll Med Genet 13:155–160 Alonso-Espinaco V et al (2011) Novel MLH1 duplication identified in Colombian families with Lynch syndrome. Genet Med Off J Am Coll Med Genet 13:155–160
16.
Zurück zum Zitat Wielandt A et al (2012) Lynch syndrome: selection of families by microsatellite instability and immunohistochemistry. Rev Med Chil 140:1132–1139CrossRefPubMed Wielandt A et al (2012) Lynch syndrome: selection of families by microsatellite instability and immunohistochemistry. Rev Med Chil 140:1132–1139CrossRefPubMed
17.
Zurück zum Zitat Dominguez-Valentin M et al (2013) Mutation spectrum in South American Lynch syndrome families. Hered Cancer Clin Pr 11:18CrossRef Dominguez-Valentin M et al (2013) Mutation spectrum in South American Lynch syndrome families. Hered Cancer Clin Pr 11:18CrossRef
18.
Zurück zum Zitat Carneiro da Silva F et al (2015) Clinical and molecular characterization of Brazilian patients suspected to have Lynch syndrome. PLoS One 10:e0139753CrossRefPubMedPubMedCentral Carneiro da Silva F et al (2015) Clinical and molecular characterization of Brazilian patients suspected to have Lynch syndrome. PLoS One 10:e0139753CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Isidro G et al (2000) Four novel MSH2/MLH1 gene mutations in portuguese HNPCC families. Hum Mutat 15:116CrossRefPubMed Isidro G et al (2000) Four novel MSH2/MLH1 gene mutations in portuguese HNPCC families. Hum Mutat 15:116CrossRefPubMed
20.
Zurück zum Zitat Valentin MD et al (2012) Evaluation of MLH1 I219 V polymorphism in unrelated South American individuals suspected of having Lynch syndrome. Anticancer Res 32:4347–4351PubMed Valentin MD et al (2012) Evaluation of MLH1 I219 V polymorphism in unrelated South American individuals suspected of having Lynch syndrome. Anticancer Res 32:4347–4351PubMed
21.
Zurück zum Zitat Sarroca C, Alfano N, Bendin GT, Della Valle A, Dominguez CA, Quadrelli R (2000) Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. Dis Colon Rectum 43:353–362CrossRefPubMed Sarroca C, Alfano N, Bendin GT, Della Valle A, Dominguez CA, Quadrelli R (2000) Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. Dis Colon Rectum 43:353–362CrossRefPubMed
23.
Zurück zum Zitat Nuñez L, Ortiz de Rozas V, Kalfayan P, Viniegra M (2014) Censo de recursos humanos y recursos moleculares para diagnóstico y evaluación de cáncer hereditario en Argentina. Rev Argent Salúd Pública 5:25–29 Nuñez L, Ortiz de Rozas V, Kalfayan P, Viniegra M (2014) Censo de recursos humanos y recursos moleculares para diagnóstico y evaluación de cáncer hereditario en Argentina. Rev Argent Salúd Pública 5:25–29
25.
Zurück zum Zitat Warthin A (1913) Hereditary with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895–1913. Arch Int Med 12:546–555CrossRef Warthin A (1913) Hereditary with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895–1913. Arch Int Med 12:546–555CrossRef
Metadaten
Titel
Lynch syndrome in South America: past, present and future
verfasst von
Carlos A. Vaccaro
Carlos Sarroca
Benedito Rossi
Francisco Lopez-Kostner
Mev Dominguez
Natalia Causada Calo
Raul Cutait
Adriana Della Valle
Lina Nuñez
Florencia Neffa
Karin Alvarez
Maria Laura Gonzalez
Pablo Kalfayan
Henry T. Lynch
James Church
Publikationsdatum
23.03.2016
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 3/2016
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-016-9903-7

Weitere Artikel der Ausgabe 3/2016

Familial Cancer 3/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.